Literature DB >> 15192084

Disposition kinetics of propranolol isomers in the perfused rat liver.

Daniel Y Hung1, Gerhard A Siebert, Ping Chang, Yuri G Anissimov, Michael S Roberts.   

Abstract

The aim of this study was to define the determinants of the linear hepatic disposition kinetics of propranolol optical isomers using a perfused rat liver. Monensin was used to abolish the lysosomal proton gradient to allow an estimation of propranolol ion trapping by hepatic acidic vesicles. In vitro studies were used for independent estimates of microsomal binding and intrinsic clearance. Hepatic extraction and mean transit time were determined from outflow-concentration profiles using a nonparametric method. Kinetic parameters were derived from a physiologically based pharmacokinetic model. Modeling showed an approximate 34-fold decrease in ion trapping following monensin treatment. The observed model-derived ion trapping was similar to estimated theoretical values. No differences in ion-trapping values was found between R(+)- and S(-)-propranolol. Hepatic propranolol extraction was sensitive to changes in liver perfusate flow, permeability-surface area product, and intrinsic clearance. Ion trapping, microsomal and nonspecific binding, and distribution of unbound propranolol accounted for 47.4, 47.1, and 5.5% of the sequestration of propranolol in the liver, respectively. It is concluded that the physiologically more active S()-propranolol differs from the R(+)-isomer in higher permeability-surface area product, intrinsic clearance, and intracellular binding site values.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15192084     DOI: 10.1124/jpet.104.070011

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Characterization of the physiological spaces and distribution of tolbutamide in the perfused rat pancreas.

Authors:  Kent John Fanning; Michael S Roberts
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

2.  History, ethics, advantages and limitations of experimental models for hepatic ablation.

Authors:  Seok Ling Ong; Gianpiero Gravante; Matthew S Metcalfe; Ashley R Dennison
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

3.  Consideration of the Unbound Drug Concentration in Enzyme Kinetics.

Authors:  Nigel J Waters; R Scott Obach; Li Di
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.